Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Pediatric Diabetes|May 18, 2020
A pilot non-inferiority randomized controlled trial to assess automatic adjustments of insulin doses in adolescents with type 1 diabetes on multiple daily injections therapyAnas El Fathi, Emilie Palisaitis, Julia E von Oettingen, et al.
Nature Communications|September 29, 2025
A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trialAlessandra Kobayati, Anas El Fathi, Natasha Garfield, et al.
Diabetes, Obesity & Metabolism|June 14, 2020
Postprandial hyperglycaemia following insulin suspensions by the artificial pancreas: Implications for bolus calculatorsSandrine Major, Anas El Fathi, Emilie Palisaitis, et al.
Canadian Journal of Diabetes|April 23, 2021
Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory ExperimentsDorsa Majdpour, Michael A Tsoukas, Jean-François Yale, et al.
Diabetes Technology & Therapeutics|October 16, 2019
Accuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor AgeMichael Tsoukas, Joanna Rutkowski, Anas El-Fathi, et al.
Diabetes Technology & Therapeutics|October 10, 2019
The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes CampEmilie Palisaitis, Anas El Fathi, Julia E Von Oettingen, et al.
The Lancet. Digital Health|September 28, 2021
A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trialMichael A Tsoukas, Dorsa Majdpour, Jean-François Yale, et al.
Diabetes Technology & Therapeutics|October 14, 2020
Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover TrialAhmad Haidar, Laurent Legault, Marie Raffray, et al.
Diabetes Care|January 25, 2020
A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover TrialAhmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, et al.
Diabetes Technology & Therapeutics|January 8, 2025
The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular ComplicationsBoris P Kovatchev, Benjamin Lobo, Chiara Fabris, et al.
Pageof 3